Appropriate treatment of benign prostatic hyperplasia: A European panel study
No abstract is available for this document.
Research conducted by
This report is part of the RAND Corporation RAND Europe document series. RAND Europe reports (RE) were monograph/reports (MR) produced by RAND Europe. REs were published at RAND from 1998 to 2001. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors.
Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.